COVID-19

COVID-19
The World Still Hasn’t Agreed on a Pandemic Playbook

Article by Claire Klobucista

For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
For two years, the world has been battling COVID-19 with masks, vaccines, and lockdowns. But countries have largely failed to channel their shared experiences into a blueprint for action.
Feb 4, 2022
The COVID-19 Pandemic and China’s Global Health Leadership
Beijing’s pandemic management is under the microscope as it hosts the Winter Olympics. CFR’s Yanzhong Huang explains how China’s response offers opportunities for U.S. global health leadership.

Council Special Report by Yanzhong Huang Feb 3, 2022

Play
Reporting on Omicron and COVID-19 Testing
CFR’s Jennifer Nuzzo and Shalina Chatlani of the Gulf States Newsroom discuss the omicron variant, testing, and reporting on the new virus strain.

Event with Shalina Chatlani and Jennifer Nuzzo Jan 25, 2022

Will the World Ever Solve the Mystery of COVID-19’s Origin?
It is crucial to learn the facts about how COVID-19 emerged to prevent future outbreaks. But China is rebuffing calls for further investigations focusing on Wuhan.

Backgrounder by Claire Klobucista Nov 3, 2021

Billions Committed, Millions Delivered
CFR’s Think Global Health site assesses the mixed record of vaccine diplomacy.

by Samantha Kiernan, Serena Tohme, and Gayeong Song Oct 28, 2021

  • China
    China’s Hospital Admission Paradox: Institutional Design and Perverse Incentives
    Without comprehensive reforms, the sustainability of China’s healthcare system remains at risk, compromising its ability to meet the genuine medical needs of its population in the long term.
    Post by Yanzhong Huang October 25, 2024 Asia Unbound
  • Monetary Policy
    What Is the U.S. Federal Reserve?
    Over the past decade, the Fed kept interest rates low while it deployed trillions of dollars in stimulus and expanded its regulatory oversight. Now, the central bank is back in the spotlight for its battle against inflation.
    Backgrounder by James McBride , Anshu Siripurapu and Noah Berman August 15, 2024 Renewing America
  • United States
    In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech Industries
    Play
    The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.   Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.
    Event with Monique K. Mansoura, Victor Suarez and David P. Fidler June 25, 2024